Key Market Indicators
Sales of blood and blood forming organs medicines in the UK are expected to reach £1.6 billion by 2026, up from £1.4 billion in 2021, representing a 2.2% year-on-year average growth rate. Since 2000, sales in the UK have increased at a rate of 6.4% each year. In 2021, the UK was the sixth largest market, overtaken by Spain at £1.4 billion. Germany, Italy and South Korea respectively were ranked second, third and fourth. The prevalence of anemia in the UK is set to reach 62,310 hospital discharges by 2026, up from 60,020 in 2021, a 0.6% year-on-year CAGR. Since 2005, UK demand has grown by 1.5% each year. In 2021, Germany took the lead with 60,020 hospital discharges, with the UK, Germany and Poland ranked second, third and fourth respectively.
